Home > News

News

Quentin Cregan speaks for the Midlands Intellectual Property Society7 July 2016Quentin Cregan spoke at the Midlands Intellectual Property Society (MIPS) event on Thursday 7th July 2016. His talk, entitlted ‘(De-?)Europeanising IP Enforcement’ considered the interaction between the UK’s domestic IP remedies and enforcement regime, in the context of both EUMarleasing and international Jade obligations. In particular, his talk focused on the effect of EU and […]
Cartier International AG and Ors v British Sky Broadcasting and Ors6 July 2016This was the appeal of the decision of Arnold J, in which he had held that the court had jurisdiction to grant a website blocking order against the six leading internet service providers (ISPs) so that consumers in the UK could not access various websites selling counterfeit Cartier goods. The decision was upheld on appeal, […]
Glaxo Wellcome Uk Ltd (t/a Allen & Hanburys) v Sandoz Ltd (High Court) [2016] EWHC 1537 (Ch)28 June 2016This case concerns an ongoing and large scale action for Trade Mark infringement and passing off brought by Glaxo against Sandoz in relation to asthma inhalers. The UK action forms part of a series of international disputes concerning these pharmaceutical products. Glaxo owns a EUTM colour per se trade mark which is visually represented by […]
Federation International De L’automobile V (1) Gator Sports Ltd (2) Green Golf Balls Europe Ltd (3) Green Golf Ltd (4) Roman Dubov (2017)16 June 2016Jonathan Hill successfully represented the Claimant (FIA), the sporting body in charge of motor sport, in a claim in the Chancery Division for trade mark infringement and passing off in relation to articles of clothing sold by the Defendant companies after expiry of an official merchandise license relating to the World Rally Championship (WRC). Shortly […]
Hospira UK Ltd -v-Cubist Pharmaceuticals LLC [2016] EWHC 1285 (PAT)10 June 2016Richard Meade QC and Isabel Jamal represented Hospira against Cubist Pharmaceuticals in this three-patent validity trial. Hospira successfully invalidated all three patents on the basis of obviousness over various pieces of prior art. The patents concerned dosing regimens and methods of purification of a drug called daptomycin, which is used to treat gram positive infections including […]